Rivaroxaban or Aspirin in Patients With CHD & GD Undergoing PCI
Clinical trial NCT04805710 · UNKNOWN
Trial details
- NCT number
- NCT04805710
- Sponsor
- Shenyang Northern Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-17
- Primary completion
- 2022-09-16
- Enrollment
- 1020
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.